Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1979 Jan;23(1):27–30. doi: 10.1128/iai.23.1.27-30.1979

Depression of cell-mediated immunity in cholera.

D L Palmer, S N Zaman
PMCID: PMC550683  PMID: 422232

Abstract

Cholera toxin may depress cell-mediated immunity by stimulation of adenyl cyclase and production of cyclic AMP in cellular systems or when given parenterally to experimental animals. Whether or not similar effects might be found during clinical infection with Vibrio cholerae was the subject of this study. Delayed hypersensitivity reactions to skin test antigens were found to be markedly depressed in Bengali patients with cholera 24 h after fluid repletion. Skin test response rates were lower in children and in adults with the disease than in both normal adults and children or in adults with an equivalent degree of malnutrition. Patients with equal degrees of dehydration due to noncholera diarrhea were significantly less immunosuppressed. Concurrent depression of other manifestations of cell-mediated immunity was not found.

Full text

PDF
27

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRODY J. A., OVERFIELD T., HAMMES L. M. DEPRESSION OF THE TUBERCULIN REACTION BY VIRAL VACCINES. N Engl J Med. 1964 Dec 17;271:1294–1296. doi: 10.1056/NEJM196412172712505. [DOI] [PubMed] [Google Scholar]
  2. Bianco C., Patrick R., Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med. 1970 Oct 1;132(4):702–720. doi: 10.1084/jem.132.4.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Catalona W. J., Taylor P. T., Rabson A. S., Chretien P. B. A method for dinitrochlorobenzene contact sensitization. A clinicopathological study. N Engl J Med. 1972 Feb 24;286(8):399–402. doi: 10.1056/NEJM197202242860804. [DOI] [PubMed] [Google Scholar]
  4. Chisari F. V., Northrup R. S., Chen L. C. The modulating effect of cholera enterotoxin on the immune response. J Immunol. 1974 Sep;113(3):729–739. [PubMed] [Google Scholar]
  5. Folch H., Waksman B. H. The splenic suppressor cell. I. Activity of thymus-dependent adherent cells: changes with age and stress. J Immunol. 1974 Jul;113(1):127–139. [PubMed] [Google Scholar]
  6. GANGAROSA E. F., BEISEL W. R., BENYAJATI C., SPRINZ H., PIYARATN P. The nature of the gastrointestinal lesion in asiatic cholera and its relation to pathogenesis: a biopsy study. Am J Trop Med Hyg. 1960 Mar;9:125–135. doi: 10.4269/ajtmh.1960.9.125. [DOI] [PubMed] [Google Scholar]
  7. Harland P. S. Tuberculin reactions in malnourished children. Lancet. 1965 Oct 9;2(7415):719–721. doi: 10.1016/s0140-6736(65)90457-5. [DOI] [PubMed] [Google Scholar]
  8. Heiss L. I., Palmer D. L. Anergy in patients with leukocytosis. Am J Med. 1974 Mar;56(3):323–332. doi: 10.1016/0002-9343(74)90614-7. [DOI] [PubMed] [Google Scholar]
  9. Johnson M. W., Maibach H. I., Salmon S. E. Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response? N Engl J Med. 1971 Jun 3;284(22):1255–1257. doi: 10.1056/NEJM197106032842210. [DOI] [PubMed] [Google Scholar]
  10. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kantor F. S. Infection, anergy and cell-mediated immunity. N Engl J Med. 1975 Mar 20;292(12):629–634. doi: 10.1056/NEJM197503202921210. [DOI] [PubMed] [Google Scholar]
  12. Kantor H. S. Enterotoxins of Escherichia coli and vibriocholerae: tools for the molecular biologist. J Infect Dis. 1975 May;131 (Suppl):S22–S32. doi: 10.1093/infdis/131.supplement.s22. [DOI] [PubMed] [Google Scholar]
  13. Lichtenstein L. M., Henney C. S., Bourne H. R., Greenough W. B., 3rd Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest. 1973 Mar;52(3):691–697. doi: 10.1172/JCI107230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Morse S. I., Stearns C. D., Goldsmith S. R. Lymphocyte depletion induced by cholera toxin; relationship to adrenal cortical function. J Immunol. 1975 Feb;114(2 Pt 1):665–670. [PubMed] [Google Scholar]
  15. Palmer D. L., Reed W. P. Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population. J Infect Dis. 1974 Aug;130(2):132–137. doi: 10.1093/infdis/130.2.132. [DOI] [PubMed] [Google Scholar]
  16. Ryder R. W., Sack D. A., Kapikian A. Z., McLaughlin J. C., Chakraborty J., Mizanur Rahman A. S., Merson M. H., Wells J. G. Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet. 1976 Mar 27;1(7961):659–663. doi: 10.1016/s0140-6736(76)92776-8. [DOI] [PubMed] [Google Scholar]
  17. Sack R. B., Barua D., Saxena R., Carpenter C. C. Vibriocidal and agglutinating antibody patterns in cholera patients. J Infect Dis. 1966 Dec;116(5):630–640. doi: 10.1093/infdis/116.5.630. [DOI] [PubMed] [Google Scholar]
  18. Sultzer B. M., Craig J. P. Cholera toxin inhibits macromolecular synthesis in mouse spleen cells. Nat New Biol. 1973 Aug 8;244(136):178–180. doi: 10.1038/newbio244178a0. [DOI] [PubMed] [Google Scholar]
  19. Warren K. S., Mahmoud A. A., Boros D. L., Rall T. W., Mandel M. A., Carpenter C. C., Jr In vivo suppression by cholera toxin of cell-mediated and foreign body inflammatory responses. J Immunol. 1974 Mar;112(3):996–1007. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES